Pediatric Seizure Treatment Guidelines

First-Line Treatment Options

• The American Academy of Pediatrics recommends lorazepam at 0.05-0.10 mg/kg IV/IM (maximum 4 mg per dose) for pediatric seizure treatment, which may be repeated every 10-15 minutes for continued seizures 1
• Lorazepam administration requires monitoring for increased incidence of apnea, especially when combined with other sedative agents 1
• The American Academy of Pediatrics suggests always monitoring oxygen saturation and being prepared to provide respiratory support when administering lorazepam 1
• Midazolam is an alternative first-line treatment option, with an IM dose of 0.2 mg/kg (maximum: 6 mg per dose) that may be repeated every 10-15 minutes 1
• For refractory status epilepticus, midazolam can be administered as an IV loading dose of 0.15-0.20 mg/kg, followed by a continuous infusion of 1 mg/kg per minute, increasing by increments of 1 mg/kg per minute (maximum: 5 mg/kg per minute) every 15 minutes until seizures stop 1

Second-Line Treatment Options

• Phenobarbital is a second-line treatment option, administered IV at 20 mg/kg (maximum dose: 1000 mg), infused over 10 minutes, with a possible repeat dose after 15 minutes (maximum total dose: 40 mg/kg) 2
• Phenytoin is another second-line option, with a recommended dose of 20 mg/kg (maximum initial dose: 1000 mg) for children, infused over 10-20 minutes at a rate not exceeding 1 mg/kg per minute 2
• Phenytoin must be diluted in normal saline to avoid precipitation and is incompatible with glucose-containing solutions 2
• The administration of phenytoin may cause hypotension and arrhythmias, especially with rapid infusion, and requires monitoring of heart rate, with a reduction in infusion rate if heart rate decreases by 10 beats per minute 2

Seizure Management Algorithm

• Initial management of seizures involves ensuring adequate airway and oxygenation, checking blood glucose immediately, and establishing vascular or intraosseous access 3
• First-line treatment includes administering lorazepam 0.05-0.10 mg/kg IV/IO, with possible repetition if seizures continue, and consideration of rectal paraldehyde 0.4 mg/kg if IV/IO access is unavailable 1, 3
• Second-line treatment for persistent seizures includes phenytoin 18-20 mg/kg IV/IO over 20 minutes or phenobarbital 15-20 mg/kg IV/IO over 10 minutes 3
• Refractory status epilepticus management involves calling an anesthesiologist for rapid sequence intubation and considering continuous midazolam infusion 1, 3

Important Considerations

• The administration of benzodiazepines (lorazepam, diazepam, midazolam) carries an increased risk of respiratory depression, especially when given rapidly IV or combined with other sedative agents 4
• Flumazenil may be used to reverse life-threatening respiratory depression caused by benzodiazepines but will also counteract the anticonvulsant effects and may precipitate seizures 1, 4
• Failure to monitor respiratory status during and after benzodiazepine administration can lead to adverse outcomes 1, 4
• Using phenytoin with glucose-containing solutions can cause precipitation, and administering benzodiazepines too rapidly can increase the risk of respiratory depression 4, 2

Seizure Management Guidelines

First-Line Treatment

• The American Academy of Pediatrics recommends midazolam 0.2 mg/kg IM for patients without IV access, which may be repeated every 10-15 minutes 5
• Be prepared to provide respiratory support regardless of the route of administration of benzodiazepines, as recommended by the American Academy of Pediatrics 5

Second-Line Treatment

• Valproate is an effective alternative second-line agent with a loading dose of 30 mg/kg IV, showing seizure control in 88% of patients within 20 minutes, as reported by the American College of Emergency Physicians 6, 7
• Levetiracetam is another viable second-line option at 20-30 mg/kg IV, with efficacy rates similar to valproate (68-73%), according to the American College of Emergency Physicians 6, 7

Refractory Status Epilepticus Management

• Consider continuous midazolam infusion starting with a loading dose of 0.15-0.20 mg/kg, followed by 1 mg/kg/min, increasing by 1 mg/kg/min (maximum: 5 mg/kg/min) every 15 minutes until seizures stop, as recommended by the American Academy of Pediatrics 5
• Flumazenil should be avoided in patients receiving benzodiazepines for seizure control as it may precipitate seizures by reversing the anticonvulsant effects, according to the American Academy of Pediatrics 5

Status Epilepticus Management in Pediatrics

Treatment Guidelines

• The American Academy of Pediatrics recommends monitoring heart rate and reducing the infusion speed of phenytoin if it decreases by 10 beats per minute 8
• Fenobarbital has a higher risk of respiratory depression and hypotension due to its vasodilatory and cardiodepressive effects 9
• Valproic acid has demonstrated control of seizures in 58% of pediatric patients within 20 minutes after infusion 10
• Pentobarbital has shown a success rate of 92% in treating refractory status epilepticus, although it is associated with a higher incidence of hypotension requiring vasopressors (77%) 11
• The use of pentobarbital is recommended by the American Academy of Emergency Medicine for refractory status epilepticus, with a success rate of 92% 9

Treatment Algorithm

• The initial phase (0-5 minutes) of treatment includes ensuring a patent airway, administering oxygen, and monitoring vital signs, as recommended by the Pediatrics journal 8
• The first line of treatment (5-20 minutes) may include lorazepam or midazolam, with the option to repeat the dose once, although the specific details are not cited in this context
• The second line of treatment (20-40 minutes) includes options such as phenytoin, phenobarbital, or valproic acid, with specific dosing and administration guidelines provided in the context, but only valproic acid is cited 10
• Refractory status epilepticus (>40 minutes) may require intubation support from anesthesiology, initiation of continuous midazolam or pentobarbital infusion, and transfer to a pediatric intensive care unit, with pentobarbital being cited as a treatment option [8] [11]

Seizure Management with Intramuscular Midazolam

Rationale for Treatment

• Every minute of delay in seizure control increases morbidity and mortality risk, as the patient is already at 5 minutes, which is the threshold for status epilepticus, according to the American Heart Association, as published in Circulation 12

Comparison of Treatment Options

• Intraosseous access, which allows administration of lorazepam, requires additional time and equipment compared to the immediate availability of IM injection, as noted in Circulation 13

Fosphenytoin Dosing Considerations in Infants

Weight-Based Dose Calculation

• For a 7-month-old infant weighing 7-8 kg, a 210 mg PE dose would equal 26-30 mg PE/kg, which is excessive and potentially dangerous, according to the American Academy of Pediatrics 14
• The average 7-month-old weighs approximately 7-9 kg, making 210 mg PE likely an overdose, as stated by the American Academy of Pediatrics 14

Critical Dosing Considerations for Infants

• Neonates and young infants have significantly altered phenytoin pharmacokinetics that increase toxicity risk, including decreased protein binding leading to higher free phenytoin levels, as reported by the American Academy of Pediatrics 14
• Phenobarbital is preferred over phenytoin in neonates due to the increased toxicity risk associated with phenytoin, according to the American Academy of Pediatrics 14

Administration Parameters

• The maximum infusion rate for fosphenytoin should not exceed 1 mg PE/kg/min, as recommended by the American Academy of Pediatrics 14
• The recommended infusion time for the total loading dose is 10-20 minutes, according to the American Academy of Pediatrics 14
• Blood pressure should be monitored continuously during infusion, as hypotension and arrhythmias can occur, especially with rapid infusion, as stated by the American Academy of Pediatrics 14

Common Pitfalls to Avoid

• Infusing fosphenytoin too rapidly increases the risk of hypotension and cardiac arrhythmias, as reported by the American Academy of Pediatrics 14
• Using glucose-containing solutions for dilution causes precipitation, according to the American Academy of Pediatrics 14
• Failing to prepare for respiratory support when combining fosphenytoin with benzodiazepines increases the risk of apnea, as stated by the American Academy of Pediatrics 14

Immediate Action Required

• Before administering a fosphenytoin dose, the infant's actual weight should be verified and the dose recalculated as mg PE/kg, as recommended by the American Academy of Pediatrics 14
• The prescription should be confirmed to specify "mg PE" not "mg" to avoid dosing errors, according to the American Academy of Pediatrics 14
• If the dose exceeds 20 mg PE/kg, the prescriber should be contacted immediately for clarification, as stated by the American Academy of Pediatrics 14
• Cardiac monitoring and resuscitation equipment should be immediately available during administration, according to the American Academy of Pediatrics 14
• Respiratory support should be ready, especially if benzodiazepines were given first, as recommended by the American Academy of Pediatrics 14

Seizure Management Guidelines

Initial Treatment

• The American College of Emergency Physicians recommends administering IV lorazepam 4 mg at 2 mg/min immediately if IV access is readily available, as it demonstrates 65% efficacy in terminating status epilepticus, which is superior to diazepam (59.1% vs 42.6%) 15

Alternative Treatment Options

• In situations where IV access is difficult or delayed, the American Heart Association suggests that IM midazolam 0.2 mg/kg (maximum 6 mg) is superior to IV lorazepam in the prehospital setting, with 73.4% seizure cessation vs 63.4% for IV lorazepam, although the specific citation for this comparison is not provided, IM midazolam achieves therapeutic levels within 5-10 minutes due to rapid absorption from a water-soluble formulation 15

Pediatric Status Epilepticus: Airway, Vascular Access, Monitoring, and Resuscitation Guidelines

Airway Management

• The airway should be opened with a head‑tilt‑chin‑lift maneuver in actively seizing children unless cervical spine injury is suspected, as recommended by the American Heart Association (AHA) 2020 guidelines. 16
• Bag‑valve‑mask equipment and an intubation set must be readily available before administering any benzodiazepine because of the risk of respiratory depression. (AHA recommendation) 16

Vascular Access

• Intravenous (IV) or intraosseous (IO) access must be obtained immediately; IO access is considered equivalent to IV access and should be used promptly when IV cannulation is difficult, per AHA 2020 guidance. 16

Continuous Monitoring

• Continuous pulse‑oximetry (oxygen saturation) is required throughout the treatment of pediatric status epilepticus, as advised by the American Academy of Pediatrics (AAP) 2019 policy statement. 17
• Continuous blood‑pressure monitoring is essential when agents with hypotensive potential (e.g., fosphenytoin, propofol, pentobarbital) are used. (Implicit from AHA/AAP recommendations) [16][17]

Cardiopulmonary Resuscitation (CPR) Quality (if cardiac arrest occurs)

• Chest‑compression depth should be at least one‑third of the anteroposterior chest diameter in children, according to AHA 2020 CPR guidelines. 16
• Compression rate must be 100–120 compressions per minute, per AHA 2020 recommendations. 16
• The compression‑to‑ventilation ratio is 15:2 when two rescuers are present and 30:2 with a single rescuer, as stipulated by AHA 2020 guidelines. 16
• Interruptions to compressions should be minimized, and the compressor should be rotated every 2 minutes to maintain quality, per AHA 2020 standards. 16